HEALTHJun 23 · 19:58 UTCMEDPAGE TODAY

White House Denies Trump Got Unapproved Obesity Drug

The White House denied a report suggesting President Trump received the investigational obesity drug retatrutide. STAT reported that Eli Lilly and the FDA approved a compassionate use request for the medication.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

White HouseorganizationDonald TrumppersonretatrutidetopicEli LillyorganizationFDAorganizationSTATorganizationMedPage Todayorganization

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 23 · 13:06 UTC
STAT+: Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program
HEALTHJun 8 · 12:16 UTC
Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
HEALTHJun 9 · 00:54 UTC
Safety concerns over doctors prescribing experimental weight loss drug not approved by FDA
HEALTHJun 23 · 08:30 UTC
STAT+: Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
HEALTHMay 21 · 12:04 UTC
New Weight Loss Drug Retatrutide Delivers Stunning Results